GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001138995
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2023 · 41 positions · Total reported value $3.86B · Top-10 concentration 67.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 87.1% · 103 new · 16 cut · 9 exited
Active Share (vs S&P 500): 86.9% · vs QQQ: 85.9% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +1.7% · vs SPY -0.4% · Prev Value $5.23B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +1.8% · vs SPY -0.4% · Latest Value $5.56B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2023 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 41 equity positions with a combined reported value of $3.86B. The filing implies a focused portfolio: its ten largest positions account for 67.2% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2023 were THC ($585.09M), IWM ($318.65M), DXC ($297.46M). By sector, the heaviest allocations are Health Care 35.8%, Consumer Discretionary 22.6%. Versus the prior quarter, allocation shifted toward Consumer Staples (+4.4pp), Health Care (+4.0pp) and away from Communication Services (-0.8pp), Consumer Discretionary (-2.7pp).
Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 103 new positions, trimmed 16 and fully exited 9, a turnover rate of 87.1% of positions. The portfolio's overlap with the prior quarter was 65% of names.
The largest new positions opened in Q4 2023 were VTRS ($65.68M), CVS ($58.92M), TEVA ($16.75M).
Of the 9 positions fully exited versus the prior quarter, the largest were SPY ($512.98M), APTV ($81.19M), TFX ($74.78M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2023)
Fully Exited (vs previous quarter)
- SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $512.98M
- APTV APTIV PLC · prev qtr: $81.19M
- TFX TELEFLEX INCORPORATED · prev qtr: $74.78M
- DD DUPONT DE NEMOURS INC · prev qtr: $32.27M
- AVTR AVANTOR INC · prev qtr: $21.50M
- MASI MASIMO CORP · prev qtr: $18.31M
- MDT MEDTRONIC PLC · prev qtr: $14.10M
- MSFT MICROSOFT CORP · prev qtr: $9.45M
Insider Transactions (Form 4)
Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 138 US equity positions with a combined value of $5.56B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-73695 (status: Approved), registered 2012-03-30
- Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 6 private funds, of which 6 hedge funds
Portfolio Structure
- 138 positions · $5.56B reported value (Q3 2026)
- Top 10 holdings = 58.3% of reported value
- Largest position: GPN (GLOBAL PMTS INC) at 10.4%
- Average position size: $40.30M
Sector Tilt
- Health Care 27.8%
- Consumer Discretionary 24.5%
- Industrials 21.7%
- (classified holdings cover 92% of value)
Quarterly Activity
- Q3 2026: 103 new, 16 added, 16 reduced, 9 exited
- 3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
7.74M | $585.09M | 15.17% | Add | |
| 2 |
|
1.59M | $318.65M | 8.26% | Add | |
| 3 |
|
13.01M | $297.46M | 7.71% | Add | |
| 4 |
|
1.70M | $259.36M | 6.72% | Reduce | |
| 5 |
|
1.95M | $247.41M | 6.42% | Add | |
| 6 |
|
24.65M | $228.27M | 5.92% | Add | |
| 7 |
|
4.70M | $225.16M | 5.84% | Add | |
| 8 |
|
18.20M | $155.26M | 4.03% | Add | |
| 9 |
|
326.90K | $151.35M | 3.92% | Reduce | |
| 10 |
|
943.28K | $125.30M | 3.25% | Reduce | |
| 11 |
|
1.96M | $120.95M | 3.14% | Reduce | |
| 12 |
|
701.26K | $106.44M | 2.76% | Reduce | |
| 13 |
|
694.08K | $105.46M | 2.73% | Reduce | |
| 14 |
|
5.28M | $101.14M | 2.62% | Add | |
| 15 |
|
2.32M | $87.19M | 2.26% | Reduce | |
| 16 |
|
3.76M | $87.07M | 2.26% | Add | |
| 17 |
|
251.52K | $68.08M | 1.76% | Reduce | |
| 18 |
|
6.07M | $65.68M | 1.70% | New | |
| 19 |
|
746.14K | $58.92M | 1.53% | New | |
| 20 |
|
157.14K | $55.62M | 1.44% | Add | |
| 21 |
|
184.50K | $55.25M | 1.43% | Reduce | |
| 22 |
|
855.58K | $49.32M | 1.28% | Reduce | |
| 23 |
|
116.93K | $45.45M | 1.18% | Reduce | |
| 24 |
|
3.86M | $45.16M | 1.17% | Add | |
| 25 |
|
360.68K | $34.90M | 0.91% | Add | |
| 26 |
|
5.60M | $26.43M | 0.69% | Add | |
| 27 |
|
25.45M | $23.36M | 0.61% | Hold | |
| 28 |
|
203.25K | $20.49M | 0.53% | Reduce | |
| 29 |
|
37.91K | $17.88M | 0.46% | Add | |
| 30 |
|
344.26K | $17.30M | 0.45% | Reduce | |
| 31 |
|
1.60M | $16.75M | 0.43% | New | |
| 32 |
|
250.00K | $11.35M | 0.29% | Reduce | |
| 33 |
|
179.71K | $10.84M | 0.28% | New | |
| 34 |
|
291.86K | $10.54M | 0.27% | Reduce | |
| 35 |
|
8.03M | $8.68M | 0.23% | Hold | |
| 36 |
|
500.00K | $6.74M | 0.17% | New | |
| 37 |
|
176.11K | $3.13M | 0.08% | New | |
| 38 |
|
116.47K | $2.29M | 0.06% | Reduce | |
| 39 |
|
1.32M | $975.53K | 0.03% | Hold | |
| 40 |
|
15.99K | $74.05K | 0.00% | Reduce | |
| 41 |
|
1.71M | $59.97K | 0.00% | Hold | |
FAQ
What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2023-Q4?
In its 2023-Q4 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 41 equity positions worth $3.86B in aggregate; its largest disclosed positions were THC ($585.09M), IWM ($318.65M), DXC ($297.46M).
How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?
GLENVIEW CAPITAL MANAGEMENT, LLC reported $3.86B of long equity holdings across 41 positions as of 2023-Q4. Top-10 holdings account for 67.2% of reported value.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.